3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Gynecologic
1
Conditions
Leiomyoma
3
Ovarian Neoplasms
2
Endometrial Neoplasms
2
Uterine Prolapse
1
Uterine Cervical Neoplasms
1
Precancerous Conditions
1
Myofibroma
1
Metrorrhagia
1
Menstruation Disturbances
1
Hysterectomy
1
Endometriosis
1
Disease
1
Adenomyosis
1
Interventions
Colposcopy
3
Fatty Acids, Omega-3
2
Endoscopic Mucosal Resection
2
Biopsy
2
polyphenon E
1
X-Rays
1
Watchful Waiting
1
Vaginal Smears
1
Tretinoin
1
Transurethral Resection of Prostate
1
Tomography, Optical Coherence
1
Tobacco Products
1
Spectrum Analysis
1
Spectrometry, Fluorescence
1
Robotic Surgical Procedures
1
Pregnancy Tests
1
Papanicolaou Test
1
Oxycodone
1
Olive Oil
1
Music Therapy
1
Moxifloxacin
1
Morphine
1
Mindfulness-Based Stress Reduction
1
Methadone
1
Losartan
1
Laser Therapy
1
Hysterectomy
1
Human Papillomavirus DNA Tests
1
Histological Techniques
1
High-Throughput Screening Assays
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Precancerous Conditions
×
Hysterectomy
×
Clear all
NCT07120945
2026-06-02
Embrace Gyn
Medtronic - MITG
Phase NA
Active not recruiting
70 enrolled